UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease

Circulation (New York, N.Y.), 2000-12, Vol.102 (23), p.2816-2822

2000

Volltextzugriff (PDF)

Coagulation activation following estrogen administration to postmenopausal women

Thrombosis and haemostasis, 1992, Vol.68 (4), p.392

1992

Volltextzugriff (PDF)

Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations

Thrombosis and haemostasis, 2000-09, Vol.84 (3), p.396

2000

Volltextzugriff (PDF)

Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease

Journal of immunological methods, 2011-10, Vol.373 (1-2), p.45-53

2011

Volltextzugriff (PDF)

Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis

The Journal of clinical investigation, 2003-04, Vol.111 (7), p.989-999

2003

Volltextzugriff (PDF)

Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects

Circulation (New York, N.Y.), 2001-05, Vol.103 (21), p.2555-2559

2001

Volltextzugriff (PDF)

123. Antigenic differences in patients receiving velaglucerase alfa or imiglucerase treatment

Molecular genetics and metabolism, 2010-02, Vol.99 (2), p.S33

2010

Volltextzugriff (PDF)

Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease

Thrombosis and haemostasis, 1996-05, Vol.75 (5), p.767

1996

Volltextzugriff (PDF)

Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients

Blood, 1994-08, Vol.84 (4), p.1314-1319

1994

Volltextzugriff (PDF)

Tumor Necrosis Factor Infusions Have a Procoagulant Effect on the Hemostatic Mechanism of Humans

Blood, 1989-07, Vol.74 (1), p.165-172

1989

Volltextzugriff (PDF)

Monitoring “Mini-Intensity” Anticoagulation With Warfarin: Comparison of the Prothrombin Time Using a Sensitive Thromboplastin With Prothrombin Fragment F1+2 Levels

Blood, 1992-04, Vol.79 (8), p.2034-2038

1992

Volltextzugriff (PDF)

Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation

Stroke (1970), 1993-09, Vol.24 (9), p.1360-1365

1993

Volltextzugriff (PDF)

Thrombin Generation Is Not Increased in the Blood of Hemophilia B Patients After the Infusion of a Purified Factor IX Concentrate

Blood, 1990-12, Vol.76 (12), p.2540-2545

1990

Volltextzugriff (PDF)

Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses

The Journal of clinical investigation, 1987-12, Vol.80 (6), p.1535-1544

1987

Volltextzugriff (PDF)

Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo

Blood, 1992-04, Vol.79 (8), p.2039-2047

1992

Volltextzugriff (PDF)

Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1+2 measurements

Thrombosis research, 1991-09, Vol.63 (6), p.617-628

1991

Volltextzugriff (PDF)

Factor XIa induced activation of the intrinsic cascade in vivo

Thrombosis and haemostasis, 1996-03, Vol.75 (3), p.445

1996

Volltextzugriff (PDF)

Influence of anticoagulants used for blood collection on plasma prothrombin fragment F 1+2 measurements

Thrombosis research, 1991, Vol.63 (6), p.617-628

1991

Volltextzugriff (PDF)

Factor IXa-Factor Villa-Cell Surface Complex Does Not Contribute to the Basal Activation of the Coagulation Mechanism In Vivo

Blood, 1992-04, Vol.79 (8), p.2039-2047

1992

Volltextzugriff (PDF)

The oral glucose tolerance test: a comparison of the time points on the basis of limit values, normal dispersion, and reproducibility

Acta diabetologica, 1981, Vol.18 (1), p.21-26

1981

Volltextzugriff (PDF)

Dissolvable carboxymethyl cellulose/polyvinylpyrrolidone microneedle arrays for transdermal delivery of Amphotericin B to treat cutaneous leishmaniasis

International journal of biological macromolecules, 2021-07, Vol.182, p.1310-1321

2021

Volltextzugriff (PDF)

Antimicrobial core–shell electrospun nanofibers containing Ajwain essential oil for accelerating infected wound healing

International journal of pharmaceutics, 2021-06, Vol.603, p.120698-120698, Article 120698

2021

Volltextzugriff (PDF)

Response Surface Methodology of Quantitative of Heterocyclic Aromatic Amines in Fried Fish Using Efficient Microextraction Method Coupled with High-Performance Liquid Chromatography: Central Composite Design

Journal of chromatographic science, 2021-04, Vol.59 (5), p.473-481

2021

Volltextzugriff (PDF)

Recent Progresses in Development of Biosensors for Thrombin Detection

Biosensors (Basel), 2022-09, Vol.12 (9), p.767

2022

Volltextzugriff (PDF)

Cytotoxic activity of abietane diterpenoids from roots of Salvia sahendica by HPLC-based activity profiling

Revista brasileira de farmacognosia, 2018-01, Vol.28 (1), p.27-33

2018

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(27)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(18)
Humans
(15)
Biological And Medical Sciences
(12)
Male
(9)
Middle Aged
(9)
Cardiovascular System & Cardiology
(8)
Hematology
(8)
Medical Sciences
(8)
Peripheral Vascular Disease
(8)
Adult
(7)
Animals
(5)
Blood Coagulation
(5)
Female
(5)
Physical Sciences
(5)
Anticoagulants
(4)
Blood Coagulation - Drug Effects
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)
Original Article
(4)
Prothrombin - Metabolism
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease

Coagulation activation following estrogen administration to postmenopausal women

Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations

Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease

Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis

Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects

123. Antigenic differences in patients receiving velaglucerase alfa or imiglucerase treatment

Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease

Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients

Tumor Necrosis Factor Infusions Have a Procoagulant Effect on the Hemostatic Mechanism of Humans

Monitoring “Mini-Intensity” Anticoagulation With Warfarin: Comparison of the Prothrombin Time Using a Sensitive Thromboplastin With Prothrombin Fragment F1+2 Levels

Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation

Thrombin Generation Is Not Increased in the Blood of Hemophilia B Patients After the Infusion of a Purified Factor IX Concentrate

Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses

Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo

Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1+2 measurements

Factor XIa induced activation of the intrinsic cascade in vivo

Influence of anticoagulants used for blood collection on plasma prothrombin fragment F 1+2 measurements

Factor IXa-Factor Villa-Cell Surface Complex Does Not Contribute to the Basal Activation of the Coagulation Mechanism In Vivo

The oral glucose tolerance test: a comparison of the time points on the basis of limit values, normal dispersion, and reproducibility

Dissolvable carboxymethyl cellulose/polyvinylpyrrolidone microneedle arrays for transdermal delivery of Amphotericin B to treat cutaneous leishmaniasis

Antimicrobial core–shell electrospun nanofibers containing Ajwain essential oil for accelerating infected wound healing

Response Surface Methodology of Quantitative of Heterocyclic Aromatic Amines in Fried Fish Using Efficient Microextraction Method Coupled with High-Performance Liquid Chromatography: Central Composite Design

Recent Progresses in Development of Biosensors for Thrombin Detection

Cytotoxic activity of abietane diterpenoids from roots of Salvia sahendica by HPLC-based activity profiling

Suchergebnisse filtern